The 6 bullish analyst ratings for Anixa Biosciences indicate a positive outlook for the stock. The average 12-month price target of $10.83, which is up 14% from the previous average, suggests that analysts expect the stock price to rise in the short term. This positive sentiment is likely to have a positive impact on the stock price.